glp-1 drugs and lupus Frontiers Tirzepatide and lupus: what SLE
Description
Retatrutide: A Triple Incretin Receptor Agonist for Obesity Management
Myasoedova, E., Crowson, C
doi:10.1111/dom.14582 190
We're losing muscle and now our metabolism is shifting and our ability to control our blood sugar is shifting as well
The mechanisms underlying these CV benefits include promoting myocardial glucose uptake and utilization, reducing oxidative stress, inhibiting cardiomyocyte apoptosis, vasodilation, improving coronary blood flow, natriuresis, anti-inflammatory effects, renal protection, reducing plaque formation, and neurohormonal regulation (22)
